Inogen Deferred Long Term Liab vs Short Term Debt Analysis
INGN Stock | USD 8.83 0.12 1.34% |
Inogen financial indicator trend analysis is infinitely more than just investigating Inogen Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inogen Inc is a good investment. Please check the relationship between Inogen Deferred Long Term Liab and its Short Term Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Deferred Long Term Liab vs Short Term Debt
Deferred Long Term Liab vs Short Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inogen Inc Deferred Long Term Liab account and Short Term Debt. At this time, the significance of the direction appears to have weak relationship.
The correlation between Inogen's Deferred Long Term Liab and Short Term Debt is 0.37. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Inogen Inc, assuming nothing else is changed. The correlation between historical values of Inogen's Deferred Long Term Liab and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Inogen Inc are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Deferred Long Term Liab i.e., Inogen's Deferred Long Term Liab and Short Term Debt go up and down completely randomly.
Correlation Coefficient | 0.37 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Short Term Debt
Most indicators from Inogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. As of the 19th of May 2024, Selling General Administrative is likely to grow to about 79 M, while Tax Provision is likely to drop about 740 K.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 176.5M | 153.5M | 136.5M | 117.0M | Total Revenue | 358.0M | 377.2M | 315.7M | 250.3M |
Inogen fundamental ratios Correlations
Click cells to compare fundamentals
Inogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Inogen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 447.3M | 461.9M | 489.5M | 405.0M | 326.2M | 292.0M | |
Other Current Liab | 12.0M | 14.1M | 23.9M | 19.0M | 60.9M | 63.9M | |
Total Current Liabilities | 50.2M | 56.7M | 61.5M | 65.3M | 72.5M | 41.7M | |
Total Stockholder Equity | 344.6M | 349.6M | 370.2M | 297.4M | 204.8M | 222.6M | |
Property Plant And Equipment Net | 25.3M | 37.1M | 63.8M | 64.9M | 70.7M | 38.5M | |
Current Deferred Revenue | 5.5M | 7.0M | 8.6M | 8.9M | 8.0M | 4.7M | |
Net Debt | (191.3M) | (202.0M) | (208.9M) | (163.7M) | (103.6M) | (108.7M) | |
Retained Earnings | 81.4M | 75.6M | 69.3M | (14.5M) | (116.9M) | (111.1M) | |
Accounts Payable | 30.7M | 33.7M | 25.7M | 34.0M | 27K | 25.7K | |
Cash | 198.0M | 212.0M | 235.5M | 187.0M | 125.5M | 130.8M | |
Non Current Assets Total | 155.1M | 156.2M | 160.3M | 100.4M | 119.1M | 87.1M | |
Non Currrent Assets Other | 4.9M | 2.7M | 3.4M | 2.4M | 3.8M | 2.0M | |
Cash And Short Term Investments | 209.1M | 231.2M | 245.5M | 187.0M | 128.5M | 144.0M | |
Net Receivables | 37.3M | 31.8M | 25.8M | 64.4M | 42.2M | 31.3M | |
Common Stock Shares Outstanding | 22.2M | 22.0M | 22.5M | 22.9M | 23.2M | 22.7M | |
Liabilities And Stockholders Equity | 447.3M | 461.9M | 489.5M | 405.0M | 326.2M | 292.0M | |
Non Current Liabilities Total | 52.5M | 55.5M | 57.8M | 42.3M | 48.9M | 27.6M | |
Inventory | 35.7M | 24.8M | 31.9M | 34.1M | 21.8M | 19.9M | |
Other Current Assets | 10.2M | 17.9M | 26.0M | 19.2M | 14.5M | 8.7M | |
Other Stockholder Equity | 263.3M | 273.5M | 299.5M | 312.1M | 320.5M | 203.3M | |
Total Liab | 102.7M | 112.2M | 119.3M | 107.6M | 121.4M | 69.4M | |
Property Plant And Equipment Gross | 25.3M | 37.1M | 90.6M | 95.1M | 118.5M | 124.4M | |
Total Current Assets | 292.2M | 305.7M | 329.2M | 304.6M | 207.1M | 204.8M | |
Accumulated Other Comprehensive Income | (87K) | 475K | 1.5M | (243K) | 1.2M | 1.3M | |
Short Term Debt | 2.0M | 1.9M | 3.4M | 3.5M | 3.7M | 4.9M | |
Intangible Assets | 77.5M | 68.8M | 60.1M | 177K | 34.6M | 21.3M | |
Other Liab | 47.8M | 47.4M | 34.5M | 22.5M | 25.9M | 20.4M | |
Other Assets | 19.3M | 17.1M | 3.4M | 2.4M | 2.2M | 2.1M | |
Property Plant Equipment | 19.4M | 28.2M | 38.9M | 43.3M | 49.8M | 31.0M | |
Net Tangible Assets | 234.1M | 247.7M | 277.1M | 264.4M | 304.0M | 242.1M | |
Good Will | 33.0M | 33.2M | 33.0M | 32.9M | 10.1M | 16.1M | |
Retained Earnings Total Equity | 81.4M | 75.6M | 69.3M | (14.5M) | (16.7M) | (15.8M) | |
Short Term Investments | 43.7M | 11.1M | 19.3M | 10.0M | 3.0M | 2.8M | |
Deferred Long Term Liab | 9.8M | 232K | 87K | 25K | 22.5K | 21.4K | |
Capital Surpluse | 263.3M | 273.5M | 299.5M | 312.1M | 358.9M | 273.5M | |
Non Current Liabilities Other | 52.5M | 55.5M | 57.8M | 42.3M | 48.6M | 32.2M | |
Accumulated Depreciation | (44.9M) | (45.8M) | (51.7M) | (51.8M) | (46.7M) | (49.0M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Inogen Inc information on this page should be used as a complementary analysis to other Inogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Inogen Stock analysis
When running Inogen's price analysis, check to measure Inogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inogen is operating at the current time. Most of Inogen's value examination focuses on studying past and present price action to predict the probability of Inogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inogen's price. Additionally, you may evaluate how the addition of Inogen to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
CEOs Directory Screen CEOs from public companies around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Inogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (4.16) | Revenue Per Share 13.815 | Quarterly Revenue Growth 0.081 | Return On Assets (0.11) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.